Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia

Haematologica

Volumn 97, Issue 9, 2012, Pages 1401-1404

  Medeiros, Bruno C ^a   Othus, Megan ^b,c   Estey, Elihu H ^b,d   Fang, Min ^b,d   Appelbaum, Frederick R ^b,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Acute myeloid leukemia; Adults; Body mass index; Outcome

Indexed keywords

CYTARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; FEMALE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; OBESITY; OVERALL SURVIVAL; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; TREATMENT RESPONSE; COMPARATIVE STUDY; FOLLOW UP; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); REMISSION INDUCTION; SURVIVAL RATE; YOUNG ADULT;

EID: 84865746736     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.056390     Document Type: Article

References (20)

1. Estey E, Döhner H. Acute myeloid leukaemia. Lancet. 2006;368(9550):1894-907.
2. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27(17):2758-65.
3. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303 (3):235-41.
4. Franco Sassi. Obesity and the Economics of Prevention: Fit not Fat. Paris: OECD Publishing, 2010.
5. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006(13);295:1549-55.
6. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569-78.
7. Estey E, Thall P, Kantarjian H, Pierce S, Kornblau S, Keating M. Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia. Leukemia. 1997;11(10):1661-4.
8. Lange BJ, Gerbing RB, Feusner J, Feusner J, Skolnik J, Sacks N, et al. Mortality in overweight and underweight children with acute myeloid leukemia. JAMA. 2005;293 (2):203-11.
9. Medeiros BC, Othus M, Fang M, Roulston D, Appelbaum FR. Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience. Blood. 2010;116(13):2224-8.
10. Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453-74.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;52:457-81.
12. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc Series B. 1972;34:187-220.
13. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378(9793):815-25.
14. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. Geneva: World Health Organization, 2000.
15. Ogden CL, Kuczmarksi RJ, Flegal KM, Mei Z, Guo S, Wei R, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002;109(1):45-80.
16. Rodvold KA, Rushing DA, Tewksbury DA. Doxorubicin clearance in the obese. J Clin Oncol. 1988;6(8):1321-7.
17. Rosner Gl, Hargis JB, Hollis DR, Budman DR, Weiss RB, Henderson IC et al. Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from Cancer and Leukemia Group B study 8541. J Clin Oncol. 1996;14(11):3000-8.
18. Fernandez HF, Sun Z, Yao X, Litzow MR, Luger SM, Paietta EM, et al. Anthracycline dose intensification in acute myeloid leukemia. N Engl J Med. 2009;361(13): 1249-59.
19. Löwenberg B, Ossenkoppele GJ, van Putten Wm Schouten HC, Graux C, Ferrant A, et al. High-dose daunorubicin in older patients with acute myeloid leukemia. N Engl J Med. 2009;361(13):1235-48.
20. Bruserud Ø, Huang TS, Glenjen N, Gjertsen BT, Foss B. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts. Haematologica. 2002;87 (6):584-95.